BeStock  
Markets › Compare › XERS vs AMLX

XERS vs AMLX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
XERS · Xeris Pharmaceuticals$16.97 ▲ 2.11%
AMLX · Amylyx Pharmaceuticals$26.02 ▼ 0.69%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

64117171225279Nov 24, '25May 26, '26Nov 20, '26
  • XERS +141.1%
  • AMLX +75.6%

Head to head

MetricXERSAMLX
Price$16.97$26.02
Change today▲ 2.11%▼ 0.69%
Market cap$3.10B$3.35B
Return, 3 months+94.2%-31.8%
Return, year to date+116.2%+115.4%
Return, 1 year+148.5%+77.4%
P/E (TTM)––
P/B63.64.4
P/E percentile vs own 5y0th3rd
Dividend yield––
Revenue growth (YoY, latest qtr)+44.2%–
Net profit growth (YoY)+1,718.0%-32.3%
Gross margin87.4%–
Operating margin12.7%–
Net margin-1.8%–
Return on equity-27.1%-30.1%
Analyst target vs. price-2.8%+77.7%
Analyst buy share83%100%
RSI (14)8239
30-day volatility86.7%58.0%
Max drawdown, 1 year-34.9%-34.4%
Trend readStrong uptrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AMLX is the largest of the group by market value.
  • XERS has returned the most over the past year.
  • AMLX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top